CWM
ABBV icon

Castle Wealth Management’s AbbVie ABBV Stock Holding History

Castle Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$787K Buy
3,127
+161
+5% +$34.6K 0.23% 75
2026
Q1 		$645K Buy
2,966
+1,679
+130% +$372K 0.21% 73
2025
Q4 		$294K Hold
1,287
– – 0.1% 107
2025
Q3 		$298K Hold
1,287
– – 0.1% 103
2025
Q2 		$239K Sell
1,287
-438
-25% -$81.4K 0.09% 109
2025
Q1 		$361K Buy
1,725
+57
+3% +$11.1K 0.14% 91
2024
Q4 		$296K Sell
1,668
-50
-3% -$9.19K 0.12% 99
2024
Q3 		$339K Buy
1,718
+528
+44% +$98.5K 0.14% 96
2024
Q2 		$204K Buy
+1,190
New +$197K 0.1% 113
2023
Q2 		– Sell
-1,273
Closed -$203K – 112
2023
Q1 		$203K Sell
1,273
-25
-2% -$3.82K 0.16% 104
2022
Q4 		$210K Sell
1,298
-104
-7% -$15.9K 0.13% 105
2022
Q3 		$188K Hold
1,402
– – 0.11% 108
2022
Q2 		$215K Buy
+1,402
New +$214K 0.13% 105

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Castle Wealth Management's ABBV Position: Q2 2026 in Review

Castle Wealth Management increased its AbbVie (ABBV) stake by 5.4% in Q2 2026, buying an estimated $34.6K and bringing the position to 3,127 shares worth $787K. The position accounts for 0.23% of the portfolio, ranked #75.

Castle Wealth Management first reported a position in ABBV in Q2 2022 and has held it in 13 quarters since. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Castle Wealth Management held 3,127 shares of AbbVie worth $787K as of Q2 2026.
  • Castle Wealth Management bought 161 AbbVie shares in Q2 2026, an estimated $34.6K.
  • AbbVie made up 0.23% of Castle Wealth Management's portfolio in Q2 2026, its #75 holding.
  • Castle Wealth Management first reported a position in AbbVie in Q2 2022 and has held it in 13 quarters since.
  • 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Castle Wealth Management's 13F filing for Q2 2026, filed 31 Jul 2026.